Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain

Neuropsychopharmacology

Volumn 25, Issue 2, 2001, Pages 173-184

  Abe, Shuzo ^a   Suzuki, Toshihito ^a,c   Ito, Takehiko ^c,d   Yamaguchi, Mika ^a   Baba, Atsuomi ^a   Hori, Takafumi ^a   Kurita, Hirofumi ^a   Shiraishi, Hiroyasu ^a   Okado, Nobuo ^b  

^a University of Tsukuba   (Japan)

^b Neurobiology Laboratory   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Glutamate; In situ hybridization; Metabotropic glutamate receptor; NMDA antagonist; Phencyclidine; Schizophrenia

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; EGLUMETAD; GLUTAMATE RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN REGION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; MALE; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; STEREOTYPED BEHAVIOR;

EID: 0034979643     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00250-5     Document Type: Article

References (50)

1. A receptor subunit mRNAs and ligand binding sites in rat brain following phencyclidine administration
2. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine
3. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
4. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London
5. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine
6. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy
7. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
8. Schizophrenia: A subcortical neurotransmitter imbalance syndrome?
9. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats
10. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268
11. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats
12. Modulatory effects of NMDA on phosphoinositide responses evoked by the metabotropic glutamate receptor agonist 1S,3R-ACPD in neonatal rat cerebral cortex
13. Pharmacology and functions of metabotropic glutamate receptors
14. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: In vivo studies with (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′- phenylcyclopropyl)glycine, a new potent and selective antagonist
15. Hippocampal morphometry in schizophrenia by high dimensional brain mapping
16. Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices
17. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes
18. Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat
19. Anatomy and physiology of glutamate in the CNS
20. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit
21. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
22. Single photon emission computed tomography in phencyclidine and related drug abuse
23. Recent advances in the phencyclidine model of schizophrenia
24. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
25. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
26. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis of schizophrenia
27. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
28. Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3
29. Metabotropic glutamate receptors in the rat nucleus accumbens
30. Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens
31. Glutamate receptor expression in schizophrenic brain
32. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
33. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine
34. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders?
35. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
36. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
37. Metabotropic glutamate receptor mRNA expression in schizophrenic thalamus
38. Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication
39. Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice
40. An anatomy of schizophrenia
41. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats
42. Schizophrenia and glutamatergic transmission
43. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
44. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
45. Metabotropic glutamate receptors and the generation of locomotor activity: Interactions with midbrain dopamine
46. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
47. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
48. Negative symptoms and hypofrontality in chronic schizophrenia
49. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia